These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18710455)

  • 1. Auricular acupuncture: a novel treatment for vasomotor symptoms associated with luteinizing-hormone releasing hormone agonist treatment for prostate cancer.
    Harding C; Harris A; Chadwick D
    BJU Int; 2009 Jan; 103(2):186-90. PubMed ID: 18710455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life among patients with metastatic prostate cancer.
    Albertsen PC; Aaronson NK; Muller MJ; Keller SD; Ware JE
    Urology; 1997 Feb; 49(2):207-16; discussion 216-7. PubMed ID: 9037282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral medroxyprogesterone for the management of luteinizing hormone releasing hormone induced hot flashes in men with advanced prostate cancer.
    Langenstroer P; Kramer B; Cutting B; Amling C; Poultan T; Lance R; Thrasher JB
    J Urol; 2005 Aug; 174(2):642-5. PubMed ID: 16006929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effectiveness of luteinizing hormone-releasing hormone agonist or antiandrogen monotherapy in elderly men with localized prostate cancer (T1-2): a retrospective study.
    Raina R; Pahalajani G; Agarwal A; Zippe C
    Asian J Androl; 2007 Mar; 9(2):253-8. PubMed ID: 17334592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.
    Quella SK; Loprinzi CL; Sloan J; Novotny P; Perez EA; Burch PA; Antolak SJ; Pisansky TM
    J Urol; 1999 Jul; 162(1):98-102. PubMed ID: 10379749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot flashes during androgen deprivation therapy with luteinizing hormone-releasing hormone agonist combined with steroidal or nonsteroidal antiandrogen for prostate cancer.
    Sakai H; Igawa T; Tsurusaki T; Yura M; Kusaba Y; Hayashi M; Iwasaki S; Hakariya H; Hara T; Kanetake H
    Urology; 2009 Mar; 73(3):635-40. PubMed ID: 19038426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: a review of their discovery, development, and place in therapy.
    Moreau JP; Delavault P; Blumberg J
    Clin Ther; 2006 Oct; 28(10):1485-508. PubMed ID: 17157109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer.
    Ulloa EW; Salup R; Patterson SG; Jacobsen PB
    Psychooncology; 2009 Jun; 18(6):598-605. PubMed ID: 18942660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy.
    Nishiyama T; Kanazawa S; Watanabe R; Terunuma M; Takahashi K
    Int J Urol; 2004 Sep; 11(9):735-41. PubMed ID: 15379937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen deprivation therapy for prostate cancer: effects on hand function.
    Soyupek F; Soyupek S; Perk H; Ozorak A
    Urol Oncol; 2008; 26(2):141-6. PubMed ID: 18312932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Climacteric-like disorders in prostate cancer patients treated with LHRH agonists.
    Nishimura K; Yamaguchi Y; Yamanaka M; Ichikawa Y; Nagano S
    Arch Androl; 2005; 51(1):41-8. PubMed ID: 15764416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum testosterone recovery after cessation of long-term luteinizing hormone-releasing hormone agonist in patients with prostate cancer.
    Bong GW; Clarke HS; Hancock WC; Keane TE
    Urology; 2008 Jun; 71(6):1177-80. PubMed ID: 18279929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing hot flashes in men being treated for prostate cancer.
    Baum NH; Torti DC
    Geriatrics; 2007 Nov; 62(11):18-21. PubMed ID: 17999566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values.
    Wadhwa VK; Weston R; Mistry R; Parr NJ
    BJU Int; 2009 Sep; 104(6):800-5. PubMed ID: 19338564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: a pilot study.
    Hammar M; Frisk J; Grimås O; Höök M; Spetz AC; Wyon Y
    J Urol; 1999 Mar; 161(3):853-6. PubMed ID: 10022700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study.
    Jenkins VA; Bloomfield DJ; Shilling VM; Edginton TL
    BJU Int; 2005 Jul; 96(1):48-53. PubMed ID: 15963119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of the urologist and nurse from the perspective of patients with prostate cancer receiving luteinizing hormone-releasing hormone analogue therapy.
    Lebret T; Bouregba A
    BJU Int; 2008 Nov; 102(10):1419-24. PubMed ID: 18549431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acupuncture for the alleviation of hot flashes in men treated with androgen ablation therapy.
    Ashamalla H; Jiang ML; Guirguis A; Peluso F; Ashamalla M
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1358-63. PubMed ID: 20605360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acupuncture for postmenopausal hot flashes.
    Nir Y; Huang MI; Schnyer R; Chen B; Manber R
    Maturitas; 2007 Apr; 56(4):383-95. PubMed ID: 17182200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength.
    Marcora S; Oliver S; Callow N; Lemmey A; Stuart N
    J Urol; 2005 Nov; 174(5):2068-9. PubMed ID: 16217402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.